Delaware Biotechnology Institute

Center for Advanced Technology Grant Program (CAT)

2026 Application Cover Page

If you have a current CAT grant STOP here.
You may not apply for another CAT grant if you have an active grant at time of submission.
Once this application cover page has been submitted a PDF of your submission will be emailed to you as an attachment. Please attach this document as the first page of your full application, which you then will submit via email as a single PDF to catdbi@udel.edu.

NOTE: Fields with an * are required.

DBI Grant Submission Form
Grant Opportunity Selection (Choose one):

PRINCIPAL INVESTIGATOR INFORMATION

Address
Address
City
State/Province
Zip/Postal

 

INDUSTRIAL PARTNER INFORMATION (ARC Proposals)

Address
Address
City
State/Province
Zip/Postal
Is this company considered a small business (less then 400 employees)

 

PROPOSAL INFORMATION

#
$
$

NOTE: Dollar value of Budget Request & Industrial Partner Commitment above must match with budget, budget justification and partner commitment letter in the proposal.

0 of 100 max words
Does this proposal involve Human Subject Research?

NOTE: Please attach your Human Subjects approval to your proposal application.

Does this proposal involve Clinical Trials?

NOTE: Please attach your Clinical Trial approval to your proposal application.

Does this proposal involve Animal Research?

NOTE: Please attach your Animal Research approval to your proposal application.

 

POTENTIAL SCIENTIFIC REVIEWERS

plus1 Add minus1 Remove

NOTE: Names, institutional affiliations, and email addresses of up to 4 potential scientific reviewers. Professional familiarity with the applicant is permitted, however, a potential reviewer should not have a significant conflict of interest.

SUBMISSION:

Principal Investigator Assurance: I certify that the statements herein are true, complete and accurate to the best of my knowledge. I agree to complete the required grant reporting and agree that I have reviewed the proposal and consent to waived tuition and F&A.